SCHEMBL7116255

SCHEMBL7116255

CNC(=O)NS(=O)(=O)c1cc(CCNC(=O)C=Cc2ccccc2)ccc1OCCOC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.57
ALOX5 P09917 1/20 0.48
LMNA P02545 3/20 0.47
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 2/20 0.47
HPGD P15428 1/20 0.47
HTT P42858 1/20 0.47
PKM P14618 1/20 0.47
MMP1 P03956 2/20 0.47
MMP2 P08253 2/20 0.47
MMP9 P14780 2/20 0.47
POLB P06746 1/20 0.47
RECQL P46063 1/20 0.47
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
NDUFS8 O00217 1/20 0.46
COXFA4 O00483 1/20 0.46
NDUFAB1 O14561 1/20 0.46
NDUFA1 O15239 1/20 0.46
NDUFS4 O43181 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7116251 1.00 MAPT (0.57) MAPTALOX5LMNAALDH1A1KDM4E
SCHEMBL7109588 0.92 MAPT (0.55) MAPTALOX5LMNAALDH1A1KDM4E
SCHEMBL7109585 0.92 MAPT (0.55) MAPTALOX5LMNAALDH1A1KDM4E
SCHEMBL7114036 0.91 MAPT (0.55) MAPTALOX5LMNAALDH1A1KDM4E
SCHEMBL7114031 0.91 MAPT (0.55) MAPTALOX5LMNAALDH1A1KDM4E
SCHEMBL7114033 0.91 MAPT (0.55) MAPTALOX5LMNAALDH1A1KDM4E
SCHEMBL4255038 0.87 POLB (0.47) MAPTLMNAALDH1A1KDM4EHPGD
SCHEMBL4704592 0.87 POLB (0.47) MAPTLMNAALDH1A1KDM4EHPGD
SCHEMBL7659576 0.87 MAPT (0.62) MAPTALOX5LMNAALDH1A1KDM4E
SCHEMBL7659572 0.87 MAPT (0.62) MAPTALOX5LMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1243730-C Cinnamoylaminoalkyl-substd. benzenesulfonamide derivs. AVENTIS PHARMA GMBH (DE) 2006-03-01 CN disclosed
EP-1183236-B1 CINNAMOYLAMINOALKYL-SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES AVENTIS PHARMA GMBH (DE) 2003-10-22 EP disclosed
EP-1183236-A1 CINNAMOYLAMINOALKYL-SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES Aventis Pharma Deutschland GmbH (DE) 2002-03-06 EP disclosed
US-6350778-B1 CARDIOVASCULAR DISORDERS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-02-26 US disclosed
WO-2000071513-A1 CINNAMOYLAMINOALKYL-SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-11-30 WO disclosed